Most Recent
Otsuka Pharmaceuticals and Bristol Myers-Squibb can retain their defences in an ongoing patent dispute over antipsychotic drug Abilify, after the Federal Court dismissed a strike out bid by the Commonwealth of Australia over the allegedly "inconsistent" pleadings.
Westpac-owned mortgage lender RAMS Financial Services breached a franchise agreement by failing to supply a Brisbane-based franchisee with information about nearby broker-originated customers, a judge has found.
Construction giant Lendlease has been temporarily restrained from beginning major demolition work for the Allianz Stadium redevelopment in Sydney until a judge rules on two legal challenges to the $729 million project.
The lead plaintiff in a class action alleging National Australia Bank pushed worthless credit card insurance onto its customers is disputing the bank's claims that it had no power to negotiate the terms of the policies.
Judgments in two appeals challenging the legality of common fund orders issued by courts in class actions will be handed down this week, and the rulings could have a profound effect on how class actions are run by lawyers and their funders in the future.
Hytera has challenged Motorola's claims that it owns the copyright for the digital radio source code that's at the centre of copyright allegations against the Chinese radio maker.
A judge has rejected a bid by Bellamy's to limit the recoverable costs of rival law firms running joint class actions against the baby food maker, saying he would deal with any unjustified duplication later, not now.
A leading female partner at Piper Alderman, who is suing the firm's other partners for sex discrimination, has told a court their attempt to oust her from the partnership was based on groundless claims of bullying and was a case of "skulduggery".
AFT Pharmaceuticals has filed a lawsuit seeking to pre-empt competitor Reckitt Benckiser from pursuing a lawsuit against it over recent ads for its painkiller Maxigesic.
Unilever is not ready to put its long-running consumer case against competitor Beiersdorf to rest, filing a challenge to a ruling that Beiersdorf did not make misleading claims about its Nivea clinical strength deodorant products.